P.O. Box 3660, Riyadh 11481, Mail Code 1515 (KAIMRC)
+966 (11) 429-4444
+966 (11) 429-4440

Therapeutic Liposome and Method of Treating a Subject having Cancer

Therapeutic liposome comprises bilayer (101) having an internal compartment, where bilayer comprises cis-9,12,15-octadecatrienoic acid, and phospholipid having fatty acid chain of carbon chain length C12 to C24. The cis-9,12,15-octadecatrienoic acid is not attached to the phospholipid, and phospholipid comprises head group and selected from choline, ethanolamine, serine, and inositol. The beta-glucan (103) derived from oat, where beta-glucan is encapsulated into internal compartment having cholesterol (104) and doxorubicin (105).

USE – Therapeutic liposome for treating cancer, which includes ovarian cancer, multiple myeloma, sarcoma, colorectal cancer, and breast cancer (claimed).

ADVANTAGE – The therapeutic liposome improved target cancer, in vivo retention and immune response activation.

Patent Number(s): US9655847-B1

Related Posts